Market News AIOpen the app

HCWB stock news · HCW Biologics Inc.

Stories about HCW Biologics Inc. (HCWB) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for HCWB

Follow HCW Biologics Inc. (HCWB) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for HCWB
Free on the App Store and Google Play, or on the web.
  1. Nov 5, 2026, 9:48 AM ET · Market

    HCW Biologics Inc. signed a deal to issue two secured promissory notes worth $10.2 million.

    Bad for HCWB

    HCW Biologics arranged $10.2 million in secured notes, but just $3 million less costs reached the company at closing. Interest, fees, and repayment rights make the deal unfavorable.

  2. Oct 13, 2026, 8:17 AM ET · Market

    12 health care companies are changing a lot before the market opens on Tuesday.

    Neutral

    HCW Biologics shares fell about 11% before Tuesday's open, but the article gives no company news explaining the drop. It does not change the company's business outlook.

  3. Sep 25, 2026, 5:22 PM ET · Market

    12 health care companies saw big changes in their stock prices after the market closed on Friday.

    Neutral

    HCW Biologics shares fell about 5% to $1.83 after hours. The report gives no new business news, so its business outlook remains unchanged.

  4. Sep 25, 2026, 5:19 PM ET · Market

    12 health care companies saw big changes in their stock prices after the market closed on Friday.

    Neutral

    The report says HCW Biologics shares fell 5.2% after hours, but gives no business update to explain the move. It does not change the company's business outlook.

  5. Aug 14, 2026, 3:27 PM ET · Market

    HCW Biologics Inc. discloses operational results and financial status (HCWB).

    Neutral

    HCW Biologics Inc. has filed a Form 8-K detailing its results of operations and financial condition, which is crucial for investors to assess the company's current performance and future outlook. This new information could lead to immediate trading activity as investors react to the financial data.

  6. Aug 14, 2026, 3:09 PM ET · Market

    HCW Biologics Inc. disclaims reliance on earlier financial statements and associated audit reports or interim reviews (HCWB).

    Good for HCWB

    HCW Biologics Inc. has filed a Form 8-K indicating non-reliance on its previously issued financial statements, which raises concerns about the accuracy of its financial reporting and could lead to a decline in investor trust and stock price.